Skip to content

Clinical trials

Ischemic Attack, Transient trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Attack, Transient Phase: Not applicable Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20052
20062
20071
20083
20093
20106
20116
20125
20133
20142
20158
201613
20172
20187
20196
20205
20214
20223
20236
20243
20259
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting24
Unknown status22
Terminated3
Withdrawn2
Not yet recruiting2
Suspended2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development4
Sunnybrook Health Sciences Centre3
Beijing Tiantan Hospital2
Case Western Reserve University2
Cierra2
Hamad Medical Corporation2
Helse Nord-Trøndelag HF2
Icahn School of Medicine at Mount Sinai2
Karolinska Institutet2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Attack, Transient115
Stroke83
Ischemic Stroke28
Atrial Fibrillation10
Hypertension9
Carotid Stenosis5
Diabetes Mellitus5
Anxiety Disorders4
Atherosclerosis4
Cardiovascular Diseases4

Trials

Showing 76 to 100 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.